In recent years controversy has swirled around the role of inflammation in cardiovascular disease and the relative worth of measuring novel risk factors like CRP. Now, in a new paper published in the New England Journal of Medicine, researchers from the Emerging Risk Factors Collaboration provide detailed calculations that estimate the benefits of adding two of…
Recent Comments